human
coronavirus
cov
mostli
caus
common
cold
mild
selflimit
zoonot
transmiss
cov
recent
identifi
middl
east
respiratori
syndrom
mer
cov
sever
acut
respiratori
syndrom
sar
cov
hand
may
associ
sever
lower
respiratori
tract
infect
articl
review
clinic
patholog
data
avail
mer
compar
sar
importantli
chest
radiograph
imag
result
patient
mer
show
featur
resembl
find
organ
pneumonia
differ
lesion
sar
patient
show
fibrocellular
intraalveolar
organ
bronchiol
obliteran
organ
pneumonialik
pattern
find
line
differ
induct
cytopatholog
chang
induct
host
gene
respons
sensit
antivir
effect
interferon
vitro
compar
merscov
sarscov
challeng
translat
find
integr
pictur
mer
pathogenesi
human
develop
intervent
strategi
eventu
allow
effect
control
newli
emerg
infecti
diseas
coronavirus
cov
larg
envelop
positivesens
rna
virus
infect
bird
wide
rang
mammal
includ
human
virus
compos
structur
protein
hold
rel
long
around
kb
positivestrand
genom
figur
occur
worldwid
caus
diseas
medic
veterinari
signific
gener
infect
local
respiratori
enter
andor
nervou
system
although
system
diseas
observ
number
host
speci
present
six
cov
identifi
infect
human
human
cov
predominantli
caus
mild
respiratori
tract
infect
character
upper
respiratori
tract
diseas
includ
coryza
cough
sore
throat
virus
occasion
induc
lower
respiratori
tract
diseas
includ
bronchiti
bronchiol
pneumonia
contrast
two
recent
emerg
cov
induc
sever
lower
respiratori
infect
may
fatal
middl
east
respiratori
syndrom
merscov
sever
acut
respiratori
syndrom
sarscov
sar
outbreak
start
china
rapid
global
spread
humantohuman
transmiss
halt
number
case
report
world
health
organ
includ
death
ten
year
later
mer
outbreak
start
middl
east
still
ongo
total
number
laboratoryconfirm
case
report
includ
fatal
far
report
describ
autopsi
fatal
merscov
case
publish
therefor
stage
one
specul
patholog
merscov
human
howev
insight
pathogenesi
patholog
potenti
merscov
may
obtain
compar
contrast
epidemiolog
clinic
manifest
host
cell
respons
merscov
infect
sarscov
may
also
caus
lifethreaten
lower
respiratori
tract
diseas
receptor
dipeptidyl
peptidas
emerg
merscov
human
dromedari
camel
potenti
earlier
time
bat
facilit
figur
humantohuman
spread
merscov
seem
effici
report
hospit
outbreak
travel
return
middl
east
close
contact
hospit
outbreak
mostli
due
persontoperson
transmiss
haemodialysi
unit
intens
care
unit
inpati
unit
patient
infect
merscov
singl
monophylet
clade
outbreak
among
healthcar
worker
hospit
due
overcrowd
inadequ
infect
control
measur
still
unclear
whether
transmiss
persontoperson
contact
occur
via
larg
respiratori
droplet
due
cough
sneez
sar
via
fomit
also
episod
transmiss
clearli
defin
report
take
place
symptomat
incub
phase
repeat
test
sputum
nasopharyng
swab
bronchoalveolar
lavag
bal
differ
time
point
need
provid
better
understand
larger
cluster
patient
observ
al
hasa
jeddah
may
primarili
relat
humantohuman
transmiss
merscov
superspread
event
describ
sar
outbreak
note
thu
far
may
due
overal
lower
level
viru
shed
upper
respiratori
tract
contribut
lower
transmiss
seen
sar
result
outbreak
restrict
compar
sar
although
futur
adapt
merscov
human
may
potenti
increas
humantohuman
transmiss
may
alter
virul
viru
caus
sever
diseas
respect
control
mer
rapid
isol
rigor
infect
control
practic
may
end
suffic
limit
outbreak
includ
standard
contact
airborn
precaut
wear
surgic
mask
glove
gown
enter
room
infect
suspect
patient
remov
leav
dromedari
camel
infect
merscov
may
show
diseas
still
may
excret
merscov
cov
bat
also
use
entri
receptor
nasal
fluid
faec
potenti
milk
urin
therefor
recommend
avoid
contact
camel
drink
raw
camel
milk
camel
urin
eat
meat
thoroughli
cook
also
peopl
work
come
contact
dromedari
camel
peopl
work
camel
farm
slaughterhous
market
camelrac
facil
also
veterinarian
risk
practis
good
person
hygien
wear
facial
protect
protect
cloth
feasibl
mer
patient
acquir
infect
middl
east
subsequ
led
limit
humantohuman
transmiss
cluster
healthcar
worker
travelrel
case
outsid
region
mild
sever
even
fatal
respiratori
diseas
median
incub
period
merscov
infect
day
current
data
indic
overal
men
women
becom
infect
median
age
year
rang
year
fatal
observ
patient
year
clinic
symptom
observ
includ
fever
cough
sore
throat
short
breath
myalgia
chest
pain
malais
gastrointestin
symptom
diarrhoea
vomit
abdomin
pain
less
common
symptom
includ
chill
wheez
palpit
confus
respiratori
symptom
mainli
relat
lower
respiratori
tract
diseas
dyspnoea
cough
fever
upper
respiratori
tract
diseas
report
infrequ
larg
proport
sever
ill
patient
requir
mechan
ventil
interestingli
mani
report
secondari
case
show
mild
respiratori
symptom
asymptomat
radiolog
mer
patient
reveal
mild
sever
pulmonari
consolid
chest
radiograph
larg
percentag
patient
admit
hospit
show
airspac
interstiti
opac
subtl
extens
unilater
bilater
focal
diffus
distribut
air
space
opac
variabl
distribut
describ
reticular
reticulonodular
demonstr
thicken
bronchovascular
area
comput
tomographi
ct
examin
hospit
patient
mer
reveal
bilater
mostli
subpleur
basilar
airspac
involv
groundglass
opac
limit
consolid
fact
lesion
found
subpleur
peribronchovascular
region
suggest
organ
pneumonia
cours
infect
merscov
mainli
detect
lower
respiratori
tract
earlier
infect
viru
detect
upper
oppos
lower
respiratori
tract
although
viru
detect
urin
blood
mer
patient
consist
find
indic
system
infect
occur
potenti
risk
factor
develop
sever
diseas
obes
diabet
mellitu
endstag
renal
diseas
cardiac
diseas
hypertens
lung
diseas
includ
asthma
cystic
fibrosi
immunosuppress
condit
complic
describ
fatal
case
hyperkalaemia
associ
ventricular
tachycardia
dissemin
intravascular
coagul
lead
cardiac
arrest
pericard
multiorgan
failur
one
report
demonstr
stillbirth
merscov
infect
compar
casecontrol
group
mer
patient
like
admit
intens
care
unit
higher
mortal
rate
surviv
rate
patient
detect
via
activ
surveil
system
higher
clinic
identifi
case
coinfect
pathogen
also
describ
frequent
relev
critic
factor
diseas
progress
uncertain
laboratori
analys
blood
mer
patient
reveal
mild
sever
abnorm
haematolog
abnorm
includ
elev
leukocyt
count
lymphopenia
case
show
lymphocytosi
thrombocytopenia
coagulopathi
laboratori
find
includ
elev
creatinin
lactat
dehydrogenas
alanin
aminotransferas
aspart
aminotransferas
level
suggest
renal
liver
diseas
failur
mer
compar
sar
mani
similar
clinic
symptom
respiratori
diseas
becom
appar
small
differ
jma
van
den
brand
et
al
median
incub
period
slightli
longer
time
mer
day
sar
day
sar
wide
spectrum
clinic
symptom
describ
similar
seen
mer
fever
chill
diarrhoea
pneumonia
condit
sever
ill
patient
present
acut
hypox
respiratori
failur
often
requir
mechan
ventil
although
virus
consid
respiratori
virus
gastrointestin
infect
symptom
describ
sar
mer
patient
casefat
rate
may
seem
higher
merscov
around
sarscov
whether
result
higher
virul
merscov
clear
sinc
mani
merscov
infect
may
gone
unnot
similar
comorbid
describ
mer
sar
mer
compar
sar
predominantli
diabet
type
chronic
renal
diseas
import
comorbid
sar
age
signific
risk
factor
develop
sever
diseas
similarli
mer
fatal
occur
patient
age
year
laboratori
find
often
show
higher
level
paramet
associ
liver
kidney
dysfunct
sar
describ
case
mer
although
acut
renal
failur
often
seen
mer
complic
pregnanc
matern
mortal
stillbirth
describ
sar
thu
far
rare
seen
mer
case
may
attribut
decreas
matern
toler
hypoxia
reduc
fetal
oxygen
flow
due
respiratori
diseas
importantli
chest
radiograph
imag
result
patient
mer
show
opac
distribut
lesion
resembl
find
organ
pneumonia
seen
patient
pandem
influenza
viru
differ
lesion
sar
patient
show
fibrocellular
intraalveolar
organ
bronchiol
obliteran
organ
pneumonia
boop
like
pattern
thu
although
clinic
symptom
may
rel
similar
sar
mer
patient
mechan
lead
diseas
may
actual
differ
far
report
describ
autopsi
fatal
merscov
case
publish
clinic
data
xray
sever
case
mer
describ
human
sever
progress
pneumonia
may
suspect
describ
sar
diffus
alveolar
damag
dad
acut
phase
prolif
chang
later
phase
diseas
pulmonari
fibrosi
seen
frequent
sar
includ
patient
surviv
infect
absenc
accur
followup
mer
patient
limit
inform
exact
cours
diseas
long
term
comparison
epidemiolog
clinic
manifest
host
cell
respons
merscov
infect
infect
sarscov
may
provid
insight
pathogenesi
patholog
potenti
merscov
sar
patient
gross
patholog
respiratori
tract
demonstr
variabl
consolid
pulmonari
oedema
haemorrhag
congest
pleural
effus
review
histopatholog
sar
show
dad
exud
phase
prolif
phase
fibrot
phase
exud
phase
seen
patient
initi
day
diseas
character
necrosi
alveolar
bronchiolar
bronchial
epitheli
cell
intralumin
oedema
fibrin
exud
hyalin
membran
format
haemorrhag
infiltr
inflammatori
cell
monocyt
macrophag
lymphocyt
neutrophil
alveolar
wall
lumina
prolif
phase
day
show
interstiti
alveolar
fibrosi
bronchiol
obliteran
organ
pneumonia
boop
regener
type
ii
pneumocyt
hyperplasia
multinucl
giant
cell
fibrot
phase
day
show
interstiti
thicken
fibrosi
booplik
pattern
inflammatori
cell
mainli
histiocyt
lymphocyt
far
clinic
data
mer
patient
demonstr
similar
diseas
mer
howev
limit
evid
develop
fibrosi
endstag
acut
respiratori
distress
syndrom
ard
induc
merscov
sever
anim
speci
rhesu
macaqu
macaca
mulatta
cynomolgu
macaqu
macaca
fasciculari
marmoset
callithrix
jacchu
ferret
mustela
putoriu
mice
mu
muri
syrian
hamster
mesocricetu
auratu
rabbit
oryctolagu
cuniculu
guineapig
cavia
porcellu
dromedari
camel
camelu
dromedariu
experiment
infect
merscov
studi
patholog
chang
result
viral
infect
howev
absenc
descript
studi
patholog
chang
lung
human
mer
patient
difficult
interpret
data
experiment
merscov
anim
infect
experi
overal
outcom
merscov
infect
subsequ
develop
lower
respiratori
diseas
seem
variabl
differ
anim
speci
inocul
merscov
rhesu
macaqu
infect
merscov
intratrach
combin
inocul
rout
rhesu
macaqu
develop
increas
bodi
temperatur
day
postinfect
dpi
transient
clinic
sign
increas
respir
rate
cough
haematolog
show
increas
total
white
blood
cell
neutrophil
dpi
decreas
lymphocyt
dpi
radiograph
imag
reveal
local
infiltr
interstiti
mark
gross
patholog
dpi
congest
littl
indic
acut
pneumonia
histopatholog
dpi
multifoc
mildtomoder
interstiti
pneumonia
character
thicken
alveolar
septa
oedema
fibrin
macrophag
neutrophil
intralumin
alveolar
macrophag
neutrophil
multinucl
giant
cell
fibrin
slough
epitheli
cell
perivascular
inflammatori
infiltr
present
interstitium
dpi
type
ii
pneumocyt
hyperplasia
alveolar
oedema
fibrin
deposit
hyalin
membran
situ
hybrid
ish
immunohistochemistri
ihc
demonstr
presenc
viru
rna
antigen
express
type
ii
pneumocyt
alveolar
macrophag
rhesu
macaqu
inocul
intratrach
viru
present
lung
dpi
nasal
oropharyng
rectal
swab
organ
kidney
trachea
brain
heart
liver
spleen
intestin
rtpcr
viru
titrat
rhesu
macaqu
combin
inocul
rout
viru
present
predominantli
nasal
swab
dpi
urogenit
rectal
swab
viru
also
present
bronchoalveolar
lavag
bal
respiratori
tract
kidney
upregul
express
level
proinflammatori
cytokin
chemokin
chemotaxi
neutrophil
activ
matrix
metalloproteinas
mmp
seen
serum
similarli
cynomolgu
macaqu
infect
merscov
show
viru
replic
lower
respiratori
tract
lung
limit
infiltr
observ
differ
day
infect
van
den
brand
et
al
unpublish
observ
figur
thu
macaqu
anim
model
fulli
depict
sever
sometim
fatal
pneumonia
seen
human
patient
marmoset
infect
high
dose
merscov
median
tissu
cultur
infect
dose
tcid
via
intratrach
intranas
oral
ocular
rout
develop
sever
diseas
rhesu
macaqu
dpi
respir
rate
increas
loss
appetit
develop
openmouth
breath
labour
breath
dpi
anim
euthan
end
experi
signific
alter
blood
demonstr
except
hypoproteinaemia
sever
ill
anim
radiolog
xray
show
progress
mild
sever
interstiti
infiltr
start
dpi
resolv
dpi
gross
patholog
show
multifoc
consolid
increas
rel
lung
weight
histopatholog
multifoc
coalesc
moder
mark
bronchointerstiti
pneumonia
centr
around
termin
bronchiol
adjac
alveoli
anim
speci
includ
dromedari
camel
act
reservoir
speci
viru
suggest
induc
limit
clinic
symptom
case
report
far
overt
clinic
diseas
absent
dromedari
camel
posit
merscov
dromedari
camel
middl
east
africa
spain
found
harbour
merscovspecif
antibodi
dromedari
camel
inocul
intratrach
intranas
intraconjunctiv
merscov
nasal
discharg
seen
dpi
excret
viru
nose
viru
found
fecal
sampl
urin
one
dromedari
b
sinc
wildtyp
innat
immunedefici
mice
becom
infect
merscov
infect
mous
model
gener
transduc
mice
recombin
nonrepl
adenoviru
express
human
host
cell
receptor
mice
show
widespread
express
airway
alveolar
epitheli
cell
merscov
infect
mortal
age
mice
lose
weight
abund
viru
lung
clear
dpi
lung
antigen
express
perivascular
peribronchiolar
lymphocyt
infiltr
progress
interstiti
pneumonia
diseas
sever
typei
ifn
signal
cell
respons
necessari
viru
clearanc
although
mer
sar
resembl
clinic
vitro
studi
highlight
remark
differ
virus
respect
growth
characterist
receptor
usag
host
respons
suggest
pathogenesi
may
quit
differ
one
way
predict
chang
lung
merscov
infect
use
human
tissu
infect
ex
vivo
hock
et
al
demonstr
widespread
merscov
antigen
express
type
ii
alveolar
cell
ciliat
bronchial
epithelium
uncili
cuboid
cell
termin
bronchiol
use
spectral
confoc
microscopi
viru
antigen
also
found
endotheli
cell
pulmonari
vessel
rare
alveolar
macrophag
electron
microscopi
reveal
alveolar
epitheli
damag
consist
detach
type
ii
alveolar
epitheli
cell
associ
disrupt
tight
junction
chromatin
condens
nuclear
fragment
membran
bleb
latter
suggest
apoptosi
although
ex
vivo
model
fulli
mimic
situat
vivo
chang
line
observ
cell
line
infect
merscov
sever
cytopath
effect
observ
human
hepatoma
cell
infect
merscov
sever
due
sarscov
infect
although
vivo
relev
observ
remain
unclear
also
name
identifi
receptor
merscov
hcov
receptor
identifi
date
exopeptidas
although
proteolyt
activ
necessari
viru
bind
receptor
enter
host
cell
compar
analysi
hcov
receptor
express
across
respiratori
tract
human
may
provid
clue
regard
differ
pathobiolog
hcov
cell
line
ex
vivo
lung
cultur
express
type
ii
alveolar
cell
ciliat
noncili
bronchial
epithelium
bronchial
submucos
gland
endothelium
alveolar
macrophag
leukocyt
larg
correspond
viral
tropism
ex
vivo
human
lung
cultur
show
infect
noncili
cell
bronchi
bronchiol
endotheli
cell
type
ii
pneumocyt
rare
alveolar
macrophag
remark
bind
site
differ
differ
speci
explain
anim
infect
merscov
sarscov
use
differ
receptor
entri
cell
angiotensinconvert
enzym
show
part
similar
celltyp
tropism
seen
human
express
ciliat
bronchial
epitheli
cell
type
ii
pneumocyt
arteri
venou
endotheli
cell
tissu
upper
respiratori
tract
suggest
tissu
primari
site
entranc
sarscov
sarscov
infect
cell
ciliat
bronchial
epitheli
cell
bronchiol
type
ii
pneumocyt
endotheli
cell
compar
genom
provid
way
studi
molecular
basi
host
respons
differ
relat
viral
pathogen
demonstr
previous
sarscov
infect
differ
primat
host
speci
present
one
compar
vitro
studi
use
merscov
perform
cell
differenti
polar
ciliat
cell
permit
replic
sarscov
merscov
similar
level
howev
merscov
induc
substanti
cytopath
effect
start
h
infect
wherea
sarscov
maintain
steadi
replic
cell
viabil
h
infect
hand
merscov
seem
sensit
prophylact
therapeut
treatment
infect
vitro
sarscov
addit
merscov
induc
much
greater
dysregul
host
respons
infect
sarscov
merscov
specif
downregul
gene
involv
antigenpresent
pathway
could
substanti
implic
develop
adapt
immun
respons
respect
analysi
immun
respons
human
infect
merscov
limit
data
two
patient
differ
diseas
outcom
avail
date
bal
serum
patient
poor
outcom
decreas
interferon
ifn
well
decreas
express
retino
inducibleacid
gene
rig
melanoma
differentiationassoci
protein
interferon
regulatori
factor
irf
involv
recognit
virus
innat
immun
system
patient
poor
outcom
also
high
level
cxcmotif
chemokin
ligand
cxcl
interleukin
il
may
result
lower
express
higher
level
patient
surviv
rapid
clearanc
viru
increas
level
note
sar
develop
sever
lower
respiratori
tract
diseas
correl
partli
aberr
immun
respons
unbalanc
cytokin
chemokin
profil
level
cytokin
chemokin
blood
elev
monocyt
chemotact
protein
mcp
ccmotif
ligand
monokin
induc
mig
ifninduc
protein
transform
growth
factor
tgf
chemokin
import
chemotaxi
activ
neutrophil
monocyt
correspond
infiltr
cell
respiratori
tract
human
sar
case
remain
determin
host
respons
domin
merscov
infect
vivo
base
result
obtain
thu
far
merscov
sarscov
may
induc
differ
pathway
time
difficult
describ
predict
patholog
sever
respiratori
diseas
merscov
infect
first
report
autopsi
human
fatal
mer
case
partli
relat
religi
background
patient
exclud
autopsi
although
limit
number
human
fatal
sar
patient
describ
studi
indic
immunopatholog
compon
may
domin
pathogenesi
sar
second
gain
knowledg
fatal
mer
human
studi
need
anim
model
could
provid
inform
replic
dynam
clinic
diseas
histolog
lesion
cellular
tropism
third
patient
sever
mer
divers
preexist
condit
therefor
may
difficult
obtain
definit
answer
studi
virusinduc
histolog
chang
may
obscur
clinic
treatment
preexist
diseas
thu
may
difficult
know
full
scope
diseas
includ
histolog
lesion
viral
cellular
tropism
pathogenesi
merscov
hand
although
better
descript
studi
sar
regard
patholog
induc
lower
respiratori
tract
provid
limit
benefit
develop
intervent
strategi
therapeut
corticosteroid
use
treatment
sar
produc
variabl
improv
less
fever
reduc
inflammatori
infiltr
better
oxygen
promis
result
obtain
administr
ifn
sar
patient
fact
vitro
studi
demonstr
merscov
sensit
type
ifn
sarscov
overal
current
avail
data
merscov
suggest
patient
risk
sever
exacerb
infect
elderli
patient
patient
underli
comorbid
condit
patient
may
abl
combat
viral
infect
type
ifn
host
respons
effici
patient
group
age
comorbid
condit
describ
neg
effect
abil
mount
strong
type
ifn
respons
sensit
merscov
vitro
type
ifn
may
indic
type
ifn
use
prophylactictherapeut
intervent
strategi
vivo
gener
human
cov
infect
caus
rel
mild
respiratori
diseas
children
mani
healthi
adult
sever
exacerb
cov
diseas
lower
respiratori
tract
involv
seem
occur
elderli
andor
patient
underli
comorbid
possibl
lack
preexist
immun
sarscov
merscov
human
popul
result
higher
infect
rate
adult
elderli
sar
outbreak
normal
observ
nonsar
human
cov
lead
higher
morbid
mortal
altern
viral
factor
includ
encod
differ
accessori
viral
gene
may
play
decis
role
determin
pathogenesi
overal
number
potenti
key
vivo
vitro
differ
merscov
sarscov
infect
includ
radiograph
differ
suggest
differ
type
pneumonia
larg
differ
cytopath
effect
differ
host
respons
infect
differ
sensit
type
ifn
vitro
observ
point
differ
diseasecaus
mechan
warrant
studi
effect
two
virus
differ
cell
popul
vitro
ex
vivo
vivo
outcom
may
signific
implic
develop
intervent
strategi
